Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation

被引：61

作者：

Thambidorai, SK ^{[1
]}

Parakh, K ^{[1
]}

Martin, DO ^{[1
]}

Shah, TK ^{[1
]}

Wazni, O ^{[1
]}

Jasper, SE ^{[1
]}

Van Wagoner, DR ^{[1
]}

Chung, MK ^{[1
]}

Murray, RD ^{[1
]}

Klein, AL ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 06期

关键词：

D O I：

10.1016/j.amjcard.2004.06.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The relation between C-reactive protein, an inflammatory marker, and thromboembolic risk factors was investigated in 104 patients with atrial fibrillation. Tranesophageal echocardiography identified patients who had thromboembolic risk factors with greater C-reactive protein levels than those without (1.00 vs 0.302 mg/dl). C-reactive protein also correlated with clinical stroke risk factors. Increased C-reactive protein levels were also independently associated with transesophageal echocardiographic thromboembolic risk factors. (C) 2004 by Excerpta Medica, Inc.

引用

页码：805 / 807

页数：3

共 16 条

[1] Inflammation as a risk factor for atrial fibrillation [J].

Aviles, RJ ;

Martin, DO ;

Apperson-Hansen, C ;

Houghtaling, PL ;

Rautaharju, P ;

Kronmal, RA ;

Tracy, RP ;

Van Wagoner, DR ;

Psaty, BM ;

Lauer, MS ;

Chung, MK .

CIRCULATION, 2003, 108 (24) :3006-3010

[2] SMOKE-LIKE ECHO IN THE LEFT ATRIAL CAVITY IN MITRAL-VALVE DISEASE - ITS FEATURES AND SIGNIFICANCE [J].

BEPPU, S ;

NIMURA, Y ;

SAKAKIBARA, H ;

NAGATA, S ;

PARK, YD ;

IZUMI, S ;

UEOKA, M ;

MASUDA, Y ;

NAKASONE, I .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (04) :744-749

[3] C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].

CERMAK, J ;

KEY, NS ;

BACH, RR ;

BALLA, J ;

JACOB, HS ;

VERCELLOTTI, GM .

BLOOD, 1993, 82 (02) :513-520

[4] C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].

Chung, MK ;

Martin, DO ;

Sprecher, D ;

Wazni, O ;

Kanderian, A ;

Carnes, CA ;

Bauer, JA ;

Tchou, PJ ;

Niebauer, MJ ;

Natale, A ;

Van Wagoner, DR .

CIRCULATION, 2001, 104 (24) :2886-2891

[5]

DEMELLIS J, 2001, ACTA CARDIOL, V56, P375

[6] Left atrial appendage ''stunning'' after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events [J].

Grimm, RA ;

Stewart, WJ ;

Arheart, KL ;

Thomas, JD ;

Klein, AL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) :582-589

[7] Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials [J].

Hart, RG ;

Pearce, LA ;

McBride, R ;

Rothbart, RM ;

Asinger, RW .

STROKE, 1999, 30 (06) :1223-1229

[8] Atrial fibrillation and stroke - Concepts and controversies [J].

Hart, RG ;

Halperin, JL .

STROKE, 2001, 32 (03) :803-808

[9] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J].

Ridker, PM ;

Cushman, M ;

Stampfer, MJ ;

Tracy, RP ;

Hennekens, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :973-979

[10]

Rifai N, 1999, CLIN CHEM, V45, P2136

← 1 2 →